COLISEUM: Collateral Circulation in Acute Ischemic Stroke With Large Vessel Occlusion

Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04882657
Collaborator
Instituto de Salud Carlos III (Other), Complejo Hospitalario Universitario de Albacete (Other), Hospital de Cruces (Other), Hospital Clínico Universitario de Valladolid (Other), Hospitales Universitarios Virgen del Rocío (Other), Fundación de Investigación Biomédica - Hospital Universitario de La Princesa (Other), Hospital Universitario La Paz (Other), Hospital del Mar (Other), Hospital Arnau de Vilanova (Other), Complexo Hospitalario Universitario de A Coruña (Other), Red de Enfermedades Vasculares Cerebrales INVICTUS PLUS (Rd1600190024) (Other)
700
19

Study Details

Study Description

Brief Summary

Prospective multicenter study of consecutive patients with acute ischemic stroke and large intracranial vessel occlusion in which a thorough and systematic evaluation of all variables that may be related to the degree of collateral circulation is performed.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Introduction. In patients with an acute ischemic stroke due to a large-vessel intracranial occlusion (LVO), the status of the colateral circulation (CC) is related to clinical outcome and to the success of mechanical thrombectomy. However, CC is highly variable from patient to patient.

    Methods. An observational, prospective, multicenter study of 700 consecutive patients with acute ischemic stroke and a LVO. Factors to be evaluated: 1) Modifiable: Vascular risk factors, blood analysis, prior medications, vital constants (with emphasis on continuous blood pressure monitoring), head position, metrics (time to admission, Computed tomography (CT), groin puncture, end of procedure), 2) Non-modifiable: age, sex, completeness of Circle of Willis, etiology, type of mechanical thrombectomy, plasma biomarkers, genetic/epigenetic factors (a discovery phase with GWAs study and a replication phase). CC grade will be assessed by the ASITN/SIR collateral score from CT-angiography (CTA) and the Digital substraction angiography (DSA, when performed). Statistics: bivariate analyses and a logistic regression to predict CC grade (poor versus good) and CC persistence comparing CTA with DSA (4 possibilities: poor-poor, poor-good, good-poor, good-good).

    Expected results. Our study may find markers of the CC status, facilitate the design of clinical trials to improve CC grade, may find new therapeutic targets and new treatments to enhance the beneficial effects of mechanical thrombectomy.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    700 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Collateral Circulation ("Collaterome") in Acute Ischemic Stroke With Large Vessel Occlusion: A Study of Clinical, Radiological, Plasma and Genetic Factors.
    Anticipated Study Start Date :
    Jun 1, 2021
    Anticipated Primary Completion Date :
    Sep 30, 2022
    Anticipated Study Completion Date :
    Dec 31, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Collateral Circulation grade [Trough the acute phase of stroke, an average of 24 hours]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with acute ischemic stroke.

    • Large vessel occlusion of an intracranial internal artery: M1, M2 or TICA. (terminal intracranial carotid artery), as demonstrated by CTA.

    • CTA performed within the first 24 hours after stroke onset. Patients with wake-up stroke are included.

    • A previous modified Rankin Scale score of 0 to 3.

    • The patient or a legal representative signs a written consent to participate.

    Exclusion Criteria:
    • More than 24 hours from last been known to be well.

    • Occlusion of other arterial segments (vertebrobasilar circulation, A1, P1, M3, M4).

    • Age below 18 years.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
    • Instituto de Salud Carlos III
    • Complejo Hospitalario Universitario de Albacete
    • Hospital de Cruces
    • Hospital Clínico Universitario de Valladolid
    • Hospitales Universitarios Virgen del Rocío
    • Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
    • Hospital Universitario La Paz
    • Hospital del Mar
    • Hospital Arnau de Vilanova
    • Complexo Hospitalario Universitario de A Coruña
    • Red de Enfermedades Vasculares Cerebrales INVICTUS PLUS (Rd1600190024)

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
    ClinicalTrials.gov Identifier:
    NCT04882657
    Other Study ID Numbers:
    • IIBSP-COL-2019-64
    First Posted:
    May 12, 2021
    Last Update Posted:
    May 12, 2021
    Last Verified:
    May 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 12, 2021